GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LungLife AI Inc (LSE:LLA) » Definitions » YoY EBITDA Growth

LungLife AI (LSE:LLA) YoY EBITDA Growth : 42.17% (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is LungLife AI YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. LungLife AI's YoY EBITDA Growth for the quarter that ended in Jun. 2024 was 42.17%.

LungLife AI's EBITDA per Share for the six months ended in Jun. 2024 was £-0.05.

LungLife AI YoY EBITDA Growth Historical Data

The historical data trend for LungLife AI's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LungLife AI YoY EBITDA Growth Chart

LungLife AI Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial -55.00 -18.28 -188.18 26.18 32.48

LungLife AI Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -19.13 21.31 39.42 20.83 42.17

LungLife AI YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

LungLife AI's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-0.158--0.234)/ | -0.234 |
=32.48 %

LungLife AI's YoY EBITDA Growth for the quarter that ended in Jun. 2024 is calculated as:

YoY EBITDA Growth (Q: Jun. 2024 )
=(EBITDA per Share (Q: Jun. 2024 )-EBITDA per Share (Q: Jun. 2023 )) / | EBITDA per Share (Q: Jun. 2023 )) |
=(-0.048--0.083)/ | -0.083 |
=42.17 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LungLife AI YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of LungLife AI's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

LungLife AI Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LungLife AI Inc (LSE:LLA) » Definitions » YoY EBITDA Growth
Comparable Companies
Traded in Other Exchanges
LLAI:UK 9H4:Germany
Address
2545 W. Hillcrest Drive, Suite 140, Thousand Oaks, CA, USA, 91320
Website
https://www.lunglifeai.com
LungLife AI Inc is focused on a developing clinical diagnostic solutions for lung cancer. The Company generates revenue from People's Republic of China and also has its presence in the United States of America.

LungLife AI Headlines

No Headlines